vs
Side-by-side financial comparison of AlTi Global, Inc. (ALTI) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
AlTi Global, Inc. is the larger business by last-quarter revenue ($86.6M vs $62.1M, roughly 1.4× Cytek Biosciences, Inc.). AlTi Global, Inc. runs the higher net margin — -15.1% vs -70.9%, a 55.8% gap on every dollar of revenue. On growth, AlTi Global, Inc. posted the faster year-over-year revenue change (87.0% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-52.2M). Over the past eight quarters, AlTi Global, Inc.'s revenue compounded faster (30.6% CAGR vs 17.7%).
Cristal Global is the world's second-largest producer of titanium dioxide and a leading producer of titanium chemicals. It was formed when The National Titanium Dioxide Company Ltd. combined with Millennium Chemicals. The headquarters are in Jeddah, Saudi Arabia. It is a significant shareholder in Bemax, the world’s 5th largest TiO2 feedstock producer.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
ALTI vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.6M | $62.1M |
| Net Profit | $-13.1M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | -2.1% | -9.0% |
| Net Margin | -15.1% | -70.9% |
| Revenue YoY | 87.0% | 8.1% |
| Net Profit YoY | 75.6% | -557.1% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.6M | $62.1M | ||
| Q3 25 | $57.2M | $52.3M | ||
| Q2 25 | $53.1M | $45.6M | ||
| Q1 25 | $58.0M | $41.5M | ||
| Q4 24 | $46.3M | $57.5M | ||
| Q3 24 | $51.8M | $51.5M | ||
| Q2 24 | $49.5M | $46.6M | ||
| Q1 24 | $50.8M | $44.9M |
| Q4 25 | $-13.1M | $-44.1M | ||
| Q3 25 | $-84.1M | $-5.5M | ||
| Q2 25 | $-24.4M | $-5.6M | ||
| Q1 25 | $1.9M | $-11.4M | ||
| Q4 24 | $-53.8M | $9.6M | ||
| Q3 24 | $-72.5M | $941.0K | ||
| Q2 24 | $-6.4M | $-10.4M | ||
| Q1 24 | $29.7M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | -2.1% | -9.0% | ||
| Q3 25 | -49.8% | -17.6% | ||
| Q2 25 | -56.7% | -23.3% | ||
| Q1 25 | -23.3% | -36.1% | ||
| Q4 24 | -42.7% | 5.2% | ||
| Q3 24 | -18.4% | -8.2% | ||
| Q2 24 | -30.2% | -18.3% | ||
| Q1 24 | -28.9% | -23.9% |
| Q4 25 | -15.1% | -70.9% | ||
| Q3 25 | -147.0% | -10.5% | ||
| Q2 25 | -45.9% | -12.2% | ||
| Q1 25 | 3.3% | -27.5% | ||
| Q4 24 | -116.1% | 16.8% | ||
| Q3 24 | -140.0% | 1.8% | ||
| Q2 24 | -12.9% | -22.4% | ||
| Q1 24 | 58.4% | -13.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.71 | — | ||
| Q3 24 | $-0.88 | — | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $0.18 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.2M | $90.9M |
| Total DebtLower is stronger | $883.0K | — |
| Stockholders' EquityBook value | $600.1M | $341.7M |
| Total Assets | $1.2B | $461.5M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.2M | $90.9M | ||
| Q3 25 | $35.8M | $93.3M | ||
| Q2 25 | $42.4M | $75.5M | ||
| Q1 25 | $52.8M | $95.3M | ||
| Q4 24 | $64.4M | $98.7M | ||
| Q3 24 | $220.6M | $162.3M | ||
| Q2 24 | $60.0M | $177.9M | ||
| Q1 24 | $134.2M | $168.8M |
| Q4 25 | $883.0K | — | ||
| Q3 25 | $586.0K | — | ||
| Q2 25 | $673.0K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $128.4M | — | ||
| Q2 24 | $164.0M | — | ||
| Q1 24 | $183.7M | — |
| Q4 25 | $600.1M | $341.7M | ||
| Q3 25 | $607.2M | $378.6M | ||
| Q2 25 | $685.4M | $377.6M | ||
| Q1 25 | $665.2M | $379.6M | ||
| Q4 24 | $658.4M | $395.7M | ||
| Q3 24 | $707.0M | $385.5M | ||
| Q2 24 | $540.2M | $389.1M | ||
| Q1 24 | $510.9M | $392.6M |
| Q4 25 | $1.2B | $461.5M | ||
| Q3 25 | $1.2B | $494.9M | ||
| Q2 25 | $1.2B | $493.3M | ||
| Q1 25 | $1.2B | $482.6M | ||
| Q4 24 | $1.3B | $499.5M | ||
| Q3 24 | $1.4B | $491.2M | ||
| Q2 24 | $1.3B | $483.7M | ||
| Q1 24 | $1.3B | $492.1M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-51.4M | $-771.0K |
| Free Cash FlowOCF − Capex | $-52.2M | $-1.8M |
| FCF MarginFCF / Revenue | -60.3% | -2.9% |
| Capex IntensityCapex / Revenue | 0.9% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-51.4M | $-771.0K | ||
| Q3 25 | $-53.5M | $-3.9M | ||
| Q2 25 | $-19.9M | $108.0K | ||
| Q1 25 | $-30.2M | $-125.0K | ||
| Q4 24 | $-50.7M | $2.0M | ||
| Q3 24 | $-4.9M | $13.2M | ||
| Q2 24 | $-30.2M | $6.2M | ||
| Q1 24 | $-15.5M | $4.0M |
| Q4 25 | $-52.2M | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | $-20.0M | $-1.5M | ||
| Q1 25 | $-31.0M | $-974.0K | ||
| Q4 24 | $-58.2M | $1.1M | ||
| Q3 24 | $-9.4M | $12.2M | ||
| Q2 24 | $-31.2M | $5.2M | ||
| Q1 24 | $-15.7M | $3.4M |
| Q4 25 | -60.3% | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | -37.6% | -3.2% | ||
| Q1 25 | -53.4% | -2.3% | ||
| Q4 24 | -125.7% | 1.9% | ||
| Q3 24 | -18.2% | 23.7% | ||
| Q2 24 | -63.2% | 11.0% | ||
| Q1 24 | -30.9% | 7.6% |
| Q4 25 | 0.9% | 1.6% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 0.0% | 3.5% | ||
| Q1 25 | 1.3% | 2.0% | ||
| Q4 24 | 16.3% | 1.6% | ||
| Q3 24 | 8.7% | 2.0% | ||
| Q2 24 | 2.2% | 2.3% | ||
| Q1 24 | 0.4% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -15.80× | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.52× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALTI
| Management Advisory Fees | $51.1M | 59% |
| Other | $32.7M | 38% |
| Distributions From Investments | $2.9M | 3% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
